Avelios Medical is excited to announce a major milestone in its journey toward revolutionizing healthcare digitalization, having successfully raised $30,000,000 in funding. This unprecedented investment will enable Avelios Medical to accelerate the development and expansion of its state-of-the-art Hospital Information System (HIS) of the future—a treatment process-oriented digitization solution designed to streamline and optimize every aspect of hospital workflows. By harnessing the power of a modular microservices platform combined with fully structured data, Avelios empowers healthcare professionals to treat more patients and provide higher quality care, all while facilitating data-driven research and enhancing business intelligence. This infusion of capital is set to support further innovations in workflow automation, the seamless integration and development of AI algorithms, and the ongoing refinement of its user-friendly software designed specifically for healthcare settings. With a commitment to excellence, Avelios Medical strives to bridge the gap between cutting-edge technology and traditional clinical practices, ensuring that first-class patient care becomes accessible to everyone. The strategic investment not only underscores investor confidence in the company’s vision but also marks a significant step forward in the healthcare technology sector. Driven by creativity, smart thinking, and a relentless pursuit of progress, the team at Avelios is dedicated to stepping outside its comfort zone to deliver innovative solutions that transform hospital operations. As it continues to lead the way in healthcare software innovation, Avelios Medical remains steadfast in its mission to redefine patient care through digitally advanced, scalable, and effective clinical solutions.
Avelios Medical Secures $30M Series A Funding to Revolutionize Hospital Workflows and Patient Care
Recently funded · €30.0M Series aHealthcare
Get the full Avelios Medical company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
